However, in a recent study, miR-27b was found to be down-regulated in HCC and to affect the sensitivities of HCC cells to several therapeutic agents via p53 activation and CYP1B1 suppression [30]. This evidence concerns the gene CYP1B1 and hepatocellular carcinoma.